Cytogel Pharma, LLC filed an amended Form D with the Securities and Exchange Commission on 2025-12-23.
Cytogel Pharma, LLC filed an amended Form D notice of an exempt securities offering with the SEC on December 23, 2025. Its industry group is Pharmaceuticals (SEC Form D/A, December 23, 2025).
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Is this your company?
Sell to companies like Cytogel Pharma, LLC? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-12-23 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Cytogel Pharma, LLC.
Free to see. No signup.
More on the people and the money behind Cytogel Pharma, LLC, from the filings we hold.
Pharmaceuticals raises by companies based in Connecticut, filed within 90 days of this one, largest first.
Get an email when Cytogel Pharma, LLC files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Cytogel Pharma, LLC raises, hires or launches. No email unless you switch it on.
Watch Cytogel Pharma, LLC →Get the full cited report on Cytogel Pharma, LLC
What the filing shows about Cytogel Pharma, LLC
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Cytogel Pharma, LLC: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Cytogel Pharma, LLC's address as 3 Thorndal Circle, Darien, CT 06820.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Cytogel Pharma, LLC →
Amended on 2026-03-26: the figures on this page did not change. Figures on this page are from the amendment. Amended filing · Original filing
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Cytogel Pharma, LLC is a registered filer with the SEC (CIK 1491841) and has filed since 2023-07-28. 2 filings are on record, the latest on 2025-12-23.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Cytogel Pharma, LLC's Form D of 2025-12-23 names C. Maglaris, Jerry Leamon, Cassandra Klimp and 5 more as its officers, directors or promoters.
Its new offerings report $1.65M sold across 1 offering, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 157 filings in Pharmaceuticals, totalled by week.
On the filing as: Executive Officer, Director.
C. Maglaris is named as The issuer is an Llc; the "director" function is fulfilled by Managers. on the Form D that Cytogel Pharma, LLC filed with the SEC on 23 December 2025, one of 8 people that filing names.
On the filing as: Director.
Jerry Leamon is named as The issuer is an Llc; the "director" function is fulfilled by Managers. on the Form D that Cytogel Pharma, LLC filed with the SEC on 23 December 2025, one of 8 people that filing names.
On the filing as: Director.
Cassandra Klimp is named as The issuer is an Llc; the "director" function is fulfilled by Managers. on the Form D that Cytogel Pharma, LLC filed with the SEC on 23 December 2025, one of 8 people that filing names.
On the filing as: Executive Officer, Director.
Frederick Telling is named as The issuer is an Llc; the "director" function is fulfilled by Managers. on the Form D that Cytogel Pharma, LLC filed with the SEC on 23 December 2025, one of 8 people that filing names.
On the filing as: Director.
Steven Chrust is named as The issuer is an Llc; the "director" function is fulfilled by Managers. on the Form D that Cytogel Pharma, LLC filed with the SEC on 23 December 2025, one of 8 people that filing names.
On the filing as: Director.
Michael Ullmann is named as The issuer is an Llc; the "director" function is fulfilled by Managers. on the Form D that Cytogel Pharma, LLC filed with the SEC on 23 December 2025, one of 8 people that filing names.
On the filing as: Director.
Eric Lang is named as The issuer is an Llc; the "director" function is fulfilled by Managers. on the Form D that Cytogel Pharma, LLC filed with the SEC on 23 December 2025, one of 8 people that filing names.
On the filing as: Executive Officer.
Theodore Maione is named as Dr. Maione is the Issuer's Chief Scientific Officer. on the Form D that Cytogel Pharma, LLC filed with the SEC on 23 December 2025, one of 8 people that filing names.
8 people named on the filing — 3 holding an executive role and 5 as directors only.
Named as of the 2025-12-23 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Cytogel Pharma, LLC
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Cytogel Pharma, LLC: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Cytogel Pharma, LLC covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Cytogel Pharma, LLCYou get an alert in MentionFox the next time this company shows up.
If you're behind Cytogel Pharma, LLC: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Cytogel Pharma, LLC. With no account yet, you sign up free and land on the result.
https://mentionfox.com/funding/cytogel-pharma-llc-form-d-25000001